Antibody-drug conjugates (ADCs) are a class of biopharmaceutical medications created as a targeted therapy for treating cancer monoclonal antibodies bonded chemically to a drug molecule. The monoclonal antibody binds to particular proteins or receptors through linkers that kill specific cell types, such as cancer cells…